Taiwan's Twi settles with Takeda over dexlansoprazole; China Jo-Jo drugstores in sales pact with Wyeth;

> Taiwan's TWi Pharmaceuticals entered into a settlement agreement over a generic version of Takeda Pharmaceutical's Dexilant (dexlansoprazole) now under review at the U.S. Food and Drug Administration. Release

> Sinopharm Group's first quarter net profit rose 28% from a year earlier on revenues that jumped 20% to CNY55.15 billion. Release

> Guangzhou Baiyunshan Pharmaceutical's first quarter report details reorganization plans. Release

> China Jo-Jo Drugstores ($CJJD) said its subsidiary, Hangzhou Jiuzhou Grand Pharmacy signed a new sales incentive agreement with Wyeth Pharmaceutical aimed at doubling the U.S. company's sales of consumer healthcare products in 2015. Release